
|Articles|January 15, 2005
New viscous-dispersive viscoelastic found promising
Poughkeepsie, NY—DisCoVisc, a new viscous-dispersive ophthalmic viscosurgical device (OVD) from Alcon Laboratories, performed comparably to Healon in a randomized, FDA phase III clinical trial in key measurements such as endothelial cell density and IOP control, according to Satish Modi, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Beyond the surface: Tackling complex dry eye cases
2
Q&A: Anat Loewenstein discusses the use of home OCT
3
Seborrheic dermatitis linked to multiple epithelial barrier diseases
4
An Extreme Case of Demodex Blepharitis: From Misdiagnosis to Remarkable Recovery
5


















































.png)


